These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 16955107
1. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1. Illies F, Bonzel KE, Wingen AM, Latta K, Hoyer PF. Kidney Int; 2006 Nov; 70(9):1642-8. PubMed ID: 16955107 [Abstract] [Full Text] [Related]
2. Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria. Tang X, Voskoboev NV, Wannarka SL, Olson JB, Milliner DS, Lieske JC. Am J Nephrol; 2014 Nov; 39(5):376-82. PubMed ID: 24776840 [Abstract] [Full Text] [Related]
3. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure. Hoppe B, Kemper MJ, Bökenkamp A, Portale AA, Cohn RA, Langman CB. Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702 [Abstract] [Full Text] [Related]
4. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H. Kidney Int; 2006 Oct; 70(7):1305-11. PubMed ID: 16850020 [Abstract] [Full Text] [Related]
5. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria. Plumb TJ, Swee ML, Fillaus JA. Am J Kidney Dis; 2013 Dec; 62(6):1155-9. PubMed ID: 23830800 [Abstract] [Full Text] [Related]
6. Oxalate elimination via hemodialysis or peritoneal dialysis in children with chronic renal failure. Hoppe B, Graf D, Offner G, Latta K, Byrd DJ, Michalk D, Brodehl J. Pediatr Nephrol; 1996 Aug; 10(4):488-92. PubMed ID: 8865249 [Abstract] [Full Text] [Related]
7. Oxalate removal by daily dialysis in a patient with primary hyperoxaluria type 1. Yamauchi T, Quillard M, Takahashi S, Nguyen-Khoa M. Nephrol Dial Transplant; 2001 Dec; 16(12):2407-11. PubMed ID: 11733634 [Abstract] [Full Text] [Related]
8. Plasma oxalate following kidney transplantation in patients without primary hyperoxaluria. Elgstoen KB, Johnsen LF, Woldseth B, Morkrid L, Hartmann A. Nephrol Dial Transplant; 2010 Jul; 25(7):2341-5. PubMed ID: 20167571 [Abstract] [Full Text] [Related]
9. Bilateral native nephrectomy reduces systemic oxalate level after combined liver-kidney transplant: A case report. Villani V, Gupta N, Elias N, Vagefi PA, Markmann JF, Paul E, Traum AZ, Yeh H. Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28261895 [Abstract] [Full Text] [Related]
10. One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: a single-center experience. Millan MT, Berquist WE, So SK, Sarwal MM, Wayman KI, Cox KL, Filler G, Salvatierra O, Esquivel CO. Transplantation; 2003 Nov 27; 76(10):1458-63. PubMed ID: 14657686 [Abstract] [Full Text] [Related]
11. Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure. Raju DL, Cantarovich M, Brisson ML, Tchervenkov J, Lipman ML. Am J Kidney Dis; 2008 Jan 27; 51(1):e1-5. PubMed ID: 18155525 [Abstract] [Full Text] [Related]
12. Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure. Watts RW, Veall N, Purkiss P. Clin Sci (Lond); 1984 May 27; 66(5):591-7. PubMed ID: 6368103 [Abstract] [Full Text] [Related]
13. Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases. Lorenz EC, Lieske JC, Seide BM, Olson JB, Mehta R, Milliner DS. Am J Kidney Dis; 2021 May 27; 77(5):816-819. PubMed ID: 32891627 [Abstract] [Full Text] [Related]
14. Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria. Marangella M, Petrarulo M, Cosseddu D, Vitale C, Linari F. Am J Kidney Dis; 1992 Jun 27; 19(6):546-53. PubMed ID: 1595703 [Abstract] [Full Text] [Related]
15. [Sequential combined liver-kidney transplantation for a one-year-old boy with infantile primary hyperoxaluria type 1]. Motoyoshil Y, Hattori M, Chikamoto H, Nakakura H, Furue T, Miyakawa S, Kohno M, Ito K, Kai K, Nakajima I, Fuchinoue S, Teraoka S, Akiba T, Kitayama H, Wada N, Ogawa Y. Nihon Jinzo Gakkai Shi; 2006 Jun 27; 48(1):22-8. PubMed ID: 16480063 [Abstract] [Full Text] [Related]
16. Oxalate removal in type I hyperoxaluria or acquired oxalosis using HD and equilibration PD. Bunchman TE, Swartz RD. Perit Dial Int; 1994 Jun 27; 14(1):81-4. PubMed ID: 8312423 [No Abstract] [Full Text] [Related]
17. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschênes G, Unwin R, Milliner D. Nephrol Dial Transplant; 2011 Nov 27; 26(11):3609-15. PubMed ID: 21460356 [Abstract] [Full Text] [Related]
18. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004. Jamieson NV, European PHI Transplantation Study Group. Am J Nephrol; 2005 Nov 27; 25(3):282-9. PubMed ID: 15961948 [Abstract] [Full Text] [Related]
19. Long-term survival on renal replacement therapy for primary hyperoxaluria type I. Calzavara P, Marangella M, Petrarulo M, Ballanti P, Bonucci E, Calconi G, Maresca MC, da Porto A, Vianello A. Nephron; 1993 Nov 27; 63(2):217-21. PubMed ID: 8450916 [Abstract] [Full Text] [Related]
20. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial. Michael M, Groothoff JW, Shasha-Lavsky H, Lieske JC, Frishberg Y, Simkova E, Sellier-Leclerc AL, Devresse A, Guebre-Egziabher F, Bakkaloglu SA, Mourani C, Saqan R, Singer R, Willey R, Habtemariam B, Gansner JM, Bhan I, McGregor T, Magen D. Am J Kidney Dis; 2023 Feb 27; 81(2):145-155.e1. PubMed ID: 35843439 [Abstract] [Full Text] [Related] Page: [Next] [New Search]